Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis

TRAP1 (TNF receptor-associated protein), a member of the HSP90 chaperone family, is found predominantly in mitochondria. TRAP1 is broadly considered to be an anticancer molecular target. However, current inhibitors cannot distinguish between HSP90 and TRAP1, making their utility as probes of TRAP1-s...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 110; no. 17; pp. E1604 - E1612
Main Authors Yoshida, Soichiro, Tsutsumi, Shinji, Muhlebach, Guillaume, Sourbier, Carole, Lee, Min-Jung, Lee, Sunmin, Vartholomaiou, Evangelia, Tatokoro, Manabu, Beebe, Kristin, Miyajima, Naoto, Mohney, Robert P, Chen, Yang, Hasumi, Hisashi, Xu, Wanping, Fukushima, Hiroshi, Nakamura, Ken, Koga, Fumitaka, Kihara, Kazunori, Trepel, Jane, Picard, Didier, Neckers, Leonard
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 23.04.2013
National Acad Sciences
SeriesPNAS Plus
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:TRAP1 (TNF receptor-associated protein), a member of the HSP90 chaperone family, is found predominantly in mitochondria. TRAP1 is broadly considered to be an anticancer molecular target. However, current inhibitors cannot distinguish between HSP90 and TRAP1, making their utility as probes of TRAP1-specific function questionable. Some cancers express less TRAP1 than do their normal tissue counterparts, suggesting that TRAP1 function in mitochondria of normal and transformed cells is more complex than previously appreciated. We have used TRAP1-null cells and transient TRAP1 silencing/overexpression to show that TRAP1 regulates a metabolic switch between oxidative phosphorylation and aerobic glycolysis in immortalized mouse fibroblasts and in human tumor cells. TRAP1-deficiency promotes an increase in mitochondrial respiration and fatty acid oxidation, and in cellular accumulation of tricarboxylic acid cycle intermediates, ATP and reactive oxygen species. At the same time, glucose metabolism is suppressed. TRAP1-deficient cells also display strikingly enhanced invasiveness. TRAP1 interaction with and regulation of mitochondrial c-Src provide a mechanistic basis for these phenotypes. Taken together with the observation that TRAP1 expression is inversely correlated with tumor grade in several cancers, these data suggest that, in some settings, this mitochondrial molecular chaperone may act as a tumor suppressor.
Bibliography:http://dx.doi.org/10.1073/pnas.1220659110
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited* by Sue Wickner, National Cancer Institute, National Institutes of Health, Bethesda, MD, and approved March 12, 2013 (received for review November 27, 2012)
1S.Y., S.T., and G.M. contributed equally to this work.
Author contributions: S.Y., K.N., F.K., K.K., J.T., D.P., and L.N. designed research; S.Y., S.T., G.M., C.S., M.-J.L., S.L., E.V., M.T., K.B., N.M., R.P.M., Y.C., H.H., W.X., H.F., K.N., and F.K. performed research; G.M., C.S., and E.V. contributed new reagents/analytic tools; S.Y., S.T., G.M., C.S., M.-J.L., S.L., E.V., M.T., K.B., N.M., R.P.M., Y.C., H.H., H.F., K.N., F.K., K.K., J.T., D.P., and L.N. analyzed data; and S.Y., D.P., and L.N. wrote the paper.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1220659110